Literature DB >> 8922297

Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden.

R S Pritchard1, J A Baron, M Gerhardsson de Verdier.   

Abstract

The epidemiology of large bowel cancer suggests an etiological role for dietary factors. Although the evidence is inconsistent, several studies have suggested an inverse association between dietary vitamin D or calcium and colorectal cancer risk. We conducted a population-based case-control study to examine the relationship between dietary vitamin D and calcium and colorectal cancer among residents of Stockholm, Sweden. Between January 1986 and March 1988, 352 cases of colon cancer and 217 cases of rectal cancer diagnosed among living persons residing in Stockholm County were identified via a cancer surveillance network established among all the hospitals in Sweden and the Stockholm Regional Cancer Registry. Controls (512) were randomly selected from a computerized population registry. Dietary intake was assessed using a quantitative food frequency questionnaire focusing on average consumption during the preceding 5 years. Supplemental intake of vitamin D and calcium was not ascertained. Logistic regression was used to calculate odds ratios (ORs) as the measure of association between the exposure of interest (vitamin D or calcium) and cancer risk. Increasing levels of dietary vitamin D were inversely associated with the risk of colorectal cancer. The association was somewhat more pronounced for cancers of the rectum [OR, 0.5; 95% confidence interval (CI), 0.3-0.9 between the highest and lowest quartiles] than for cancers of the colon (OR, 0.6; 95% CI, 0.4-1.0) after adjustment for age, sex, and total caloric and protein intake. Dietary calcium was not associated with the adjusted risk of colon (OR, 1.2; 95% CI, 0.7-2.1) or rectal cancer (OR, 1.0; 95% CI, 0.5-1.9). Further adjustments for fat and dietary fiber intake, body mass index, and physical activity had little or no effect on the results. These results suggest that dietary vitamin D may reduce the risk of large bowel cancer, particularly rectal cancer. In addition, although some of the previous data suggested a protective effect for calcium against cancers of the large bowel, we could not document such an effect.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8922297

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  16 in total

1.  A potential role for adjunctive vitamin D therapy in the management of weight gain and metabolic side effects of second-generation antipsychotics.

Authors:  Benjamin U Nwosu; Bruce Meltzer; Louise Maranda; Carol Ciccarelli; Daniel Reynolds; Laura Curtis; Jean King; Jean A Frazier; Mary M Lee
Journal:  J Pediatr Endocrinol Metab       Date:  2011       Impact factor: 1.634

2.  Calcium, vitamin D, VDR genotypes, and epigenetic and genetic changes in rectal tumors.

Authors:  Martha L Slattery; Roger K Wolff; Jennifer S Herrick; Bette J Caan; Wade Samowitz
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

Review 3.  Colon cancer: polyps, prevention, and politics.

Authors:  G L Eastwood
Journal:  Trans Am Clin Climatol Assoc       Date:  1998

Review 4.  Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence.

Authors:  Ruoxu Dou; Kimmie Ng; Edward L Giovannucci; JoAnn E Manson; Zhi Rong Qian; Shuji Ogino
Journal:  Br J Nutr       Date:  2016-05       Impact factor: 3.718

5.  Prevalence of serum vitamin D deficiency and insufficiency in cancer: Review of the epidemiological literature.

Authors:  Digant Gupta; Pankaj G Vashi; Kristen Trukova; Christopher G Lis; Carolyn A Lammersfeld
Journal:  Exp Ther Med       Date:  2011-01-20       Impact factor: 2.447

Review 6.  The role of vitamin D in cancer prevention.

Authors:  Cedric F Garland; Frank C Garland; Edward D Gorham; Martin Lipkin; Harold Newmark; Sharif B Mohr; Michael F Holick
Journal:  Am J Public Health       Date:  2005-12-27       Impact factor: 9.308

7.  Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry.

Authors:  Jenny N Poynter; Elizabeth T Jacobs; Jane C Figueiredo; Won H Lee; David V Conti; Peter T Campbell; A Joan Levine; Paul Limburg; Loic Le Marchand; Michelle Cotterchio; Polly A Newcomb; John D Potter; Mark A Jenkins; John L Hopper; David J Duggan; John A Baron; Robert W Haile
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01-19       Impact factor: 4.254

Review 8.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

Review 9.  Diet and colorectal cancer: Review of the evidence.

Authors:  Milly Ryan-Harshman; Walid Aldoori
Journal:  Can Fam Physician       Date:  2007-11       Impact factor: 3.275

10.  Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment.

Authors:  Magdalena Milczarek; Beata Filip-Psurska; Wiesław Swiętnicki; Andrzej Kutner; Joanna Wietrzyk
Journal:  Oncol Rep       Date:  2014-06-11       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.